These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1787128)

  • 1. Review of quinolones in the treatment of infections of the skin and skin structure.
    Gentry LO
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():97-110. PubMed ID: 1787128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy with newer oral beta-lactam and quinolone agents for infections of the skin and skin structures: a review.
    Gentry LO
    Clin Infect Dis; 1992 Jan; 14(1):285-97. PubMed ID: 1571443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin.
    Parish LC; Jungkind DL
    Am J Med; 1991 Dec; 91(6A):115S-119S. PubMed ID: 1662880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic management of cutaneous bacterial infections.
    Parish LC; Witkowski JA
    Am J Med; 1991 Dec; 91(6A):106S-110S. PubMed ID: 1662878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone antibiotics: properties of the class and individual agents.
    Stratton C
    Clin Ther; 1992; 14(3):348-75; discussion 347. PubMed ID: 1638577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temafloxacin: an overview.
    Pankey GA
    Am J Med; 1991 Dec; 91(6A):166S-172S. PubMed ID: 1662889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
    Lipsky BA; Miller B; Schwartz R; Henry DC; Nolan T; McCabe A; Magner DJ; Talbot GH
    Clin Ther; 1999 Apr; 21(4):675-90. PubMed ID: 10363733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
    King A; Bethune L; Phillips I
    J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temafloxacin: in vitro comparison with five other antibacterial agents.
    Digranes A; Hardardottir H; Bottolfsen KL
    Chemotherapy; 1991; 37(2):98-105. PubMed ID: 2032475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of temafloxacin hydrochloride (TA-167 or A-62254), a new fluorinated 4-quinolone.
    Nakanishi N; Inoue M; Inoue K; Yamaguchi T; Mitsuhashi S
    Chemotherapy; 1990; 36(5):345-55. PubMed ID: 2209168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of quinolones for the treatment of acute exacerbations of chronic bronchitis.
    Chodosh S
    Am J Med; 1991 Dec; 91(6A):93S-100S. PubMed ID: 1662900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levofloxacin and sparfloxacin: new quinolone antibiotics.
    Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
    Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fluoroquinolones as treatment for infections caused by gram-positive bacteria.
    Cruciani M; Bassetti D
    J Antimicrob Chemother; 1994 Mar; 33(3):403-17. PubMed ID: 8040107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.
    Langtry HD; Lamb HM
    Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
    Barry AL; Jones RN
    J Antimicrob Chemother; 1989 Apr; 23(4):527-35. PubMed ID: 2745259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.
    Nye K; Shi YG; Andrews JM; Ashby JP; Wise R
    J Antimicrob Chemother; 1989 Sep; 24(3):415-24. PubMed ID: 2808194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.
    Paton JH; Reeves DS
    Drugs; 1988 Aug; 36(2):193-228. PubMed ID: 3053126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of fluoroquinolones in skin and skin structure infections.
    Blondeau JM
    Am J Clin Dermatol; 2002; 3(1):37-46. PubMed ID: 11817967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone treatment of skin and skin structure infections.
    Karchmer AW
    Drugs; 1999; 58 Suppl 2():82-4. PubMed ID: 10553712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.